|
FY2025
12 months to Dec 31, 2025
|
FY2024
9 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Payment of operating costs through promissory note | ||
| Interest earned on investments held in Trust Account | ||
| Unrealized gain on investments held in Trust Account | ||
| Unrealized loss (gain) on investments held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Prepaid expenses and other current assets | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Cash withdrawn from Trust Account for working capital purposes | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Private Placement Shares | ||
| Underwriter reimbursement | ||
| Repayment of promissory note – related party | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Noncash investing and financing activities: | ||
| Deferred offering costs paid directly by Sponsor in exchange for the issuance of Class B ordinary shares | ||
| Deferred offering costs paid through promissory note - related party | ||
| Deferred underwriting fee payable |
Loading...
